Literature DB >> 1496815

The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration.

J O Errecalde1, M F Landoni.   

Abstract

The pharmacokinetics of a slow-release theophylline formulation was investigated following intravenous and oral administration at 10 mg/kg in horses. A tricompartmental model was selected to describe the intravenous plasma profile. The elimination half-life (t1/2 beta) was 16.91 +/- 0.93 h, the apparent volume of distribution (Vd) was 1.35 +/- 0.18 L/kg and the body clearance (ClB) was 0.061 +/- 0.009 L kg-1 h. After oral administration the half-life of absorption was 1.24 +/- 0.30 h, and the calculated bioavailability was above 100%. The t1/2 beta after oral administration was 18.51 +/- 1.75 h, only a little longer than that after intravenous administration. The slow release formulation did not exhibit any advantage in prolonging the t1/2 beta of theophylline in the horse.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496815     DOI: 10.1007/bf01839010

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  20 in total

1.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

2.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

3.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

4.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Bioavailability of four slow-release theophylline formulations in the beagle dog.

Authors:  G D Koritz; B C McKiernan; C A Neff-Davis; I J Munsiff
Journal:  J Vet Pharmacol Ther       Date:  1986-09       Impact factor: 1.786

6.  Chronic obstructive pulmonary disease in the horse. 2: Therapy.

Authors:  J R Thomson; E A McPherson
Journal:  Equine Vet J       Date:  1983-07       Impact factor: 2.888

7.  Theophylline and dyphylline pharmacokinetics in the horse.

Authors:  J W Ayres; E G Pearson; T W Riebold; S F Chang
Journal:  Am J Vet Res       Date:  1985-12       Impact factor: 1.156

8.  Pharmacokinetic disposition of theophylline in horses after intravenous administration.

Authors:  D F Kowalczyk; J Beech; D Littlejohn
Journal:  Am J Vet Res       Date:  1984-11       Impact factor: 1.156

9.  Pharmacokinetic studies of theophylline in dogs.

Authors:  B C McKiernan; C A Neff-Davis; G D Koritz; L E Davis; D R Pheris
Journal:  J Vet Pharmacol Ther       Date:  1981-06       Impact factor: 1.786

10.  Pharmacokinetics and bioavailability of theophylline in horses.

Authors:  J O Errecalde; C Button; J D Baggot; M S Mulders
Journal:  J Vet Pharmacol Ther       Date:  1984-12       Impact factor: 1.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.